ctrl K

Price Alert

Ocuphire Pharma Inc. (OCUP)

NASDAQ: OCUP · Real-Time Price · USD

1.17

-0.16 (-12.03%)

At close: Oct 23, 2024, 10:00 PM

Ocuphire Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	30.32M	50.5M	42.63M	24.53M
Short-Term Investments	2K	15K	49K	219K
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	-636K	-10K
Receivables	5.77M	2.33M	4.85M	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	515K	102K	80K	71K
Total Current Assets	36.61M	53.95M	48.99M	26.07M
Property-Plant & Equipment	252K	n/a	6K	10K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	252K	n/a	6K	10K
Total Assets	36.86M	53.95M	48.99M	26.08M
Account Payables	3.15M	2.15M	1.07M	1.58M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	538K
Other Current Liabilities	8.15M	1.14M	902K	1.25M
Total Current Liabilities	11.29M	4.04M	2.75M	3.85M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	-636K	n/a
Total Long-Term Liabilities	n/a	n/a	1.07M	n/a
Total Liabilities	11.29M	4.04M	2.75M	3.85M
Total Debt	n/a	n/a	n/a	538K
Common Stock	3K	2K	2K	2K
Retained Earnings	-139M	-81.47M	-71.48M	-89.37M
Comprehensive Income	n/a	-0.00	n/a	n/a
Shareholders Equity	6.72M	49.91M	46.24M	22.22M
Total Investments	n/a	15K	49K	219K